 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| n |
20 µg EE OCs:
significant increases in vertebral
|
|
|
bone density
(oligomenorrheic, perimenopausal
|
|
|
women)
|
|
|
| n |
0.625 mg
conjugated equine estrogens (HRT) =
|
|
~ 5 µg EE
|
|
|
| n |
5 µg EE doses:
demonstrate bone-sparing
|
|
|
properties
|
|
|
| n |
20 µg EE OCs:
protective benefits are
|
|
|
maintained in
perimenopausal women
|
|